Ms Stem Cells Canada

The discovered potential of mesenchymal stem cells msc in treating multiple sclerosis ms has culminated in the launch of mescams mesenchymal stem cell therapy for canadian ms patients a phase ii clinical trial that is funded in part by the ms scientific research foundation research manitoba and a w food services of canada inc.

Ms stem cells canada.

Epub ahead of print summary. Cell therapy for multiple sclerosis. They have been shown to suppress inflammation and repair nerve tissue positioning them as promising candidates for the treatment of ms. Cohen ja et al.

Stem cell therapy is any treatment that uses or targets stem cells which are the types of cells that differentiate into many different specialized cells in our bodies. The research led by steve goldman professor of neurology and neuroscience at urmc and co director of the center for translational neuromedicine. Stem cells are found in both embryos and adults. Those patients with very aggressive multiple sclerosis that a stem cell transplant changes the course of the disease says dr.

The ms society of canada has announced funding for the first clinical trial of its kind in canada studying the ability of mesenchymal stem cells to treat ms. One trial of 24 people with rrms found that 69 who had stem cell therapy didn t have a relapse in ms symptoms or new brain lesions which are caused by ms 5 years after treatment. The research was published in the journal cell reports. Mark freedman ottawa hospital research.

A research study in mice by investigators at the university of rochester medical center urmc suggests it would be possible to repair the brain cell damage caused by multiple sclerosis ms. That compared with only three of 55 patients given a stem cell transplant. Multiple sclerosis journal 2017. Sarkar p et al.

Pilot trial of intravenous autologous culture expanded mesenchymal stem cell transplantation in multiple sclerosis. Over an average of three years ms progressed in 34 of 55 patients on medication meaning their disabilities worsened. Canada has among the highest rates of ms in the world. The discovered potential of msc in treating ms has culminated in the launch of mescams mesenchymal stem cell therapy for canadian ms patients a phase ii clinical trial that is funded in part by the ms scientific research foundation research manitoba and a w food services of canada inc.